Drugs Starting with Z
BioSniper tracks 46 drugs and molecules whose names begin with Z — each linked to its developers, clinical trials, indications, and FDA decisions. Data availability reflects the latest successfully ingested source records; source and as-of dates are shown where available.
Browse A–ZZ
- zafirlukast1
- Zaire ebolavirus envelope glycoprotein
- zalifrelimab1
- zaloblideg1
- zamristobart
- zanidatamab
- zanubrutinib1
- zanzalintinib1
- zavegepant2
- zelebrudomide
- zeleciment basivarsen
- zeleciment rostudirsen
- zelenectide pevedotin2
- zelicapavir
- zervimesine1
- zetomipzomib1
- zidesamtinib
- ziihera1
- zilebesiran
- zilganersen
- zilretta2
- zilucoplan1
- zilurgisertib
- zimberelimab1
- zimislecel
- zinc gluconate
- zipalertinib1
- zl-1310
- zolacabtagene autoleucel
- zolbetuximab
- zoldonrasib1
- zoledronic acid
- zoliflodacin
- zolpidem4
- zolucatetide
- zongertinib
- zonisamide
- zopapogene imadenovec1
- zorevunersen1
- zunsemetinib1
- zunveyl1
- zuranolone2
- zusduri1
- zw171
- zw191
- zw251
From drug list to evidence case
Define what these drug programs must prove
Choose the developer, phase, trial, indication, and FDA evidence that should count in your drug thesis.